Outcomes of Irrisept Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers
Outcomes of Chlorhexidine Gluconate Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers
Sponsor: Irrimax Corporation
Listed as NCT06024590, this NA trial focuses on Diabetic Foot Ulcer and remains completed. Sponsored by Irrimax Corporation, it has been updated 7 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Aug 2025 — Sep 2025 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jun 2025 — Aug 2025 [monthly]
Recruiting NA
Phase: PHASE4 → NA
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
▶ Show 2 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Recruiting PHASE4
-
Oct 2023 — Nov 2023 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Irrimax Corporation
- Northern Illinois Foot and Ankle Specialists
For direct contact, visit the study record on ClinicalTrials.gov .